Glycaemic outcomes and the importance of active insulin time in the Pivotal trial of the MiniMed™ Advanced Hybrid Closed-Loop (AHCL) system

被引：0

作者：

Carlson, A. ^{[1
]}

Bode, B. ^{[2
]}

Christiansen, M. ^{[3
]}

Garg, S. ^{[4
]}

Kaiserman, K. ^{[5
]}

Kipnes, M. ^{[6
]}

Liljenquist, D. ^{[7
]}

Philis-Tsimikas, A. ^{[8
]}

Pop-Busui, R. ^{[9
]}

Reed, J. ^{[10
]}

Sherr, J. ^{[11
]}

Shulman, D. ^{[12
]}

Slover, R. ^{[4
]}

Thrasher, J. ^{[13
]}

机构：

[1] Pk Nicollet Int Diabet Ctr, Minneapolis, MN USA

[2] Atlanta Diabet Associates, Atlanta, GA USA

[3] Diablo Clin Res, Walnut Creek, CA USA

[4] Barbara Davis Ctr Childhood Diabet, Aurora, CO USA

[5] SoCal Diabet, Torrance, CA USA

[6] Diabet & Glandular Dis Clin, San Antonio, TX USA

[7] Rocky Mt Diabet & Osteoporosis Ctr, Idaho Fall, ID USA

[8] Scripps Whittier Diabet Inst, San Diego, CA USA

[9] Univ Michigan Hlth Syst, Ann Arbor, MI USA

[10] Endocrine Res Solut, Roswell, GA USA

[11] Yale Sch Med, New Haven, CT USA

[12] Univ S Florida, Tampa, FL 33620 USA

[13] Med Invest Inc, Little Rock, AR USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

169

引用

页码：S86 / S86

页数：1